Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Meta’s Strategic Pivot: From Virtual Worlds to AI Dominance

Robert Sasse by Robert Sasse
December 14, 2025
in AI & Quantum Computing, Earnings, Gaming & Metaverse, Tech & Software, Turnaround
0
Meta Stock
0
SHARES
26
VIEWS
Share on FacebookShare on Twitter

Meta Platforms Inc. is executing a significant strategic shift, moving its primary focus away from the metaverse and toward artificial intelligence. This realignment includes plans to reduce its workforce in the Reality Labs division by 10% to 30%, with cuts potentially starting as soon as January 2026. The market’s reaction to this corporate repositioning has been measured.

Robust Fundamentals Underpin the Shift

Despite the strategic redirection, the company’s core business remains strong. For the third quarter of 2025, Meta reported revenue of $51.24 billion, representing a 26% year-over-year increase. The number of ad impressions served across its platforms grew by 14%, while the average price per ad rose by 10%. Operating cash flow reached $30 billion.

Looking ahead, management provided fourth-quarter revenue guidance in the range of $56 to $59 billion. Capital expenditures for Q3 stood at $19.37 billion. For the full year 2025, the company anticipates spending between $70 and $72 billion, with plans for a “significantly higher” level in 2026 to fund the expansion of its AI infrastructure.

Reality Labs: A Costly Venture

The decision follows years of substantial investment in Reality Labs, the division responsible for virtual reality headsets and related social networking projects. Over the past four years, this unit has incurred losses exceeding $70 billion for Meta. These persistent losses have pressured the company’s overall margins, even as its main digital advertising operations continue to perform well.

Instead of continuing to channel vast resources into the metaverse, CEO Mark Zuckerberg is now emphasizing the augmented reality hardware business. The company intends to expand its Ray-Ban Meta Smart Glasses line. In a related move, Meta recently recruited former Apple designer Alan Dye to lead a new creative studio.

Forging AI Alliances with Media Giants

In a clear sign of its new direction, Meta entered into several commercial agreements with major media organizations in early December. Partners include CNN, Fox News, USA Today, People Inc., and Le Monde. These deals empower Meta’s AI to deliver real-time news responses through its chatbot, which is integrated across Facebook, Instagram, WhatsApp, and Messenger.

Should investors sell immediately? Or is it worth buying Meta?

These partnerships represent a notable reversal in strategy. Back in 2022, Meta had discontinued its program that paid news publishers. The company is now once again paying for content access to ensure its AI assistants remain competitive in a crowded field.

Technical Charts Flash a Cautionary Signal

From a technical analysis perspective, the stock presents a mixed outlook. A so-called “death cross” has appeared on the chart, with the 50-day moving average crossing below the 200-day moving average—a pattern not seen since May. Historically, this technical formation has often preceded periods of weaker performance.

Since reaching its all-time high of $796.25 in August 2025, Meta’s share price has declined by approximately 19%. It is currently trading within a support zone between $620 and $685.

Wall Street Maintains a Bullish Stance

Analyst sentiment remains overwhelmingly positive. Currently, 27 analysts rate the stock as a “buy,” with no “sell” ratings issued in recent months. The median price target among analysts is $825. Rosenblatt Securities holds the most bullish view with a target of $1,117, while Morgan Stanley maintains a more conservative target of $750, alongside an “overweight” rating.

Adding to shareholder returns, Meta announced on December 3 a quarterly cash dividend of $0.53 per share, payable on December 23.

Ad

Meta Stock: Buy or Sell?! New Meta Analysis from February 7 delivers the answer:

The latest Meta figures speak for themselves: Urgent action needed for Meta investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Meta: Buy or sell? Read more here...

Tags: META
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock
Analysis

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock
Analysis

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Next Post
Carpenter Stock

Carpenter Technology: A Tale of Conflicting Market Cues

Willdan Stock

Willdan Shares Gain Momentum from Major Contract Wins and Strategic Acquisition

Standard Lithium Stock

Standard Lithium Secures Key Funding Interest for Arkansas Venture

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com